Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL.
about
P1343
Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing.Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.Epigenetic silencing of LPP/miR-28 in multiple myeloma.Atom based linear index descriptors in QSAR-machine learning classifiers for the prediction of ubiquitin-proteasome pathway activity
P2860
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL.
@en
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL.
@nl
type
label
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL.
@en
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL.
@nl
prefLabel
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL.
@en
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL.
@nl
P2860
P356
P1476
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL.
@en
P2093
Chi Chiu So
Thomas Sk Wan
P2860
P2888
P356
10.1186/1475-2867-13-122
P4510
P577
2013-12-12T00:00:00Z
P5875
P6179
1007220894